TABLE 1.
Primer sequences
| Primer namea | Sequence |
|---|---|
| β-Actin FWD | 5′-CTTCTACAATGAGCTGCGTGTG-3′ |
| β-Actin REV | 5′-TTGAAGGTCTCAAACATGATCTGG-3′ |
| Eef1e1 FWD | 5′-GCAGAAGAAAAGGCAATGGT-3′ |
| Eef1e1 REV | 5′-AGGCCGTAGTACAGCAGGAT-3′ |
| GAPDH FWD | 5′-AGAATTGACAAACGGGACCT-3′ |
| GAPDH REV | 5′-GGAGGAGCAGAGAGCTTGAC-3′ |
| PGK1 FWD | 5′-CTGACTTTGGACAAGCTGGACG-3′ |
| PGK1 REV | 5′-GCAGCCTTGATCCTTTGGTTG-3′ |
| HSV-1 ICP0 FWD | 5′-GGTCCCCACTGACTCATACG-3′ |
| HSV-1 ICP0 REV | 5′-ATCCCGACCCCTCTTCTTC-3′ |
| HSV-1 TK FWD | 5′-ATACCGACGATCTGCGACCT-3′ |
| HSV-1 TK REV | 5′-TTATTGCCGTCATAGCGCGG-3′ |
| HSV-1 gB FWD | 5′-TCTGCACCATGACCAAGTG-3′ |
| HSV-1 gB REV | 5′-TGGTGAAGGTGGTGGATATG-3′ |
| HSV-1 LAT FWD | 5′-CCCTCGTCTCCTGTGATTCT-3′ |
| HSV-1 LAT REV | 5′-GGGAGACAGAAACAGGAACAT-3′ |
a
Eef1e1, eukaryotic elongation factor 1 epsilon-1; FWD, forward; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; gB, glycoprotein B; HSV-1, herpes simplex virus 1; ICP0, infected cell protein 0; LAT, latency-associated transcript; PGK1, phosphoglycerate kinase 1; REV, reverse; TK, thymidine kinase.